Structural exploration, synthesis and pharmacological evaluation of novel 5-benzylidenethiazolidine-2,4-dione derivatives as iNOS inhibitors against inflammatory diseases-Reference-Cited by-同舟云学术

Structural exploration, synthesis and pharmacological evaluation of novel 5-benzylidenethiazolidine-2,4-dione derivatives as iNOS inhibitors against inflammatory diseases

Published:2015-03 Issue: Volume:92 Page:178-190
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Ma Liang,Pei Heying,Lei Lei,He Linhong,Chen Jinying,Liang Xiaolin,Peng Aihua,Ye Haoyu,Xiang Mingli,Chen Lijuan

Funder

China Postdoctoral Science Foundation

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference26 articles.

1. Inflammation 2010: new adventures of an old flame;Medzhitov;Cell,2010

2. Origin and physiological roles of inflammation;Medzhitov;Nature,2008

3. Points of control in inflammation;Nathan;Nature,2002

4. The role of nitric oxide in inflammation and immunity;Clancy;Arthritis Rheum.,1998

5. Nitric oxide and the immune response;Bogdan;Nat. Immunol.,2001

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SKLB023 protects against inflammation and apoptosis in sepsis-associated acute kidney injury via the inhibition of toll-like receptor 4 signaling;International Immunopharmacology;2024-09

2. Thiazolidines derivatives and their anti-inflammatory activity in LPS-induced RAW 264.7 macrophages: a systematic review and meta-analysis;Natural Product Research;2024-08-21

3. Design, synthesis and biological evaluation of potent thiazolidinedione salicylic acid inhibitors against glyoxalase-I as potential anticancer agents;Medicinal Chemistry Research;2024-08-09

4. Development of novel nitric oxide production inhibitors based on the 7H-pyrrolo[2,3-d]pyrimidine scaffold;Molecular Diversity;2024-05-06

5. Design, synthesis and biological evaluation of novel 3C-like protease inhibitors as lead compounds against SARS-CoV-2;Future Medicinal Chemistry;2024-04-15